| Product NDC: | 25010-705 | 
| Proprietary Name: | Cuprimine | 
| Non Proprietary Name: | Penicillamine | 
| Active Ingredient(s): | 250 mg/1 & nbsp; Penicillamine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25010-705 | 
| Labeler Name: | Aton Pharma, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019853 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19701204 | 
| Package NDC: | 25010-705-15 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (25010-705-15) | 
| NDC Code | 25010-705-15 | 
| Proprietary Name | Cuprimine | 
| Package Description | 100 CAPSULE in 1 BOTTLE (25010-705-15) | 
| Product NDC | 25010-705 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Penicillamine | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19701204 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aton Pharma, Inc. | 
| Substance Name | PENICILLAMINE | 
| Strength Number | 250 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Antirheumatic Agent [EPC] |